Impact of genetic background and ablation of insulin receptor substrate (IRS)-3 on IRS-2 knock-out mice (Q44257211)

1 December 2017

title

Impact of genetic background and ablation of insulin receptor substrate (IRS)-3 on IRS-2 knock-out mice (English)

1 reference

1 December 2017

Yasuo Terauchi

1

1 reference

1 December 2017

Junji Matsui

2

1 reference

1 December 2017

Ryo Suzuki

3

1 reference

1 December 2017

Naoto Kubota

4

1 reference

1 December 2017

Kajuro Komeda

5

1 reference

1 December 2017

Shinichi Aizawa

6

1 reference

1 December 2017

Kazuhiro Eto

7

1 reference

1 December 2017

Satoshi Kimura

8

1 reference

1 December 2017

Ryozo Nagai

9

1 reference

1 December 2017

Kazuyuki Tobe

10

1 reference

1 December 2017

Gustav E Lienhard

11

1 reference

1 December 2017

Takashi Kadowaki

12

1 reference

1 December 2017

language of work or name

English

0 references

publication date

18 December 2002

1 reference

Journal of Biological Chemistry

1 December 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

1 December 2017

volume

278

1 reference

1 December 2017

issue

16

1 reference

1 December 2017

page(s)

14284-14290

1 reference

Transgenic approaches to the pathogenesis of NIDDM.

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211045200

Insights into molecular pathogenesis of type 2 diabetes from knockout mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211045200

Role of IRS-2 in insulin and cytokine signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211045200

The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211045200

A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211045200

Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211045200

Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211045200

Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and beta cell glucokinase genes. Genetic reconstitution of diabetes as a polygenic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211045200

4PS/insulin receptor substrate (IRS)-2 is the alternative substrate of the insulin receptor in IRS-1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211045200

Identification of a 190-kDa protein as a novel substrate for the insulin receptor kinase functionally similar to insulin receptor substrate-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211045200

Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211045200

Disruption of IRS-2 causes type 2 diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211045200

Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211045200

Insulin receptor substrate 3 is not essential for growth or glucose homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211045200

Increased insulin sensitivity and hypoglycaemia in mice lacking the p85 alpha subunit of phosphoinositide 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211045200

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211045200

The human glucokinase gene beta-cell-type promoter: an essential role of insulin promoter factor 1/PDX-1 in its activation in HIT-T15 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211045200

NADH shuttle system regulates K(ATP) channel-dependent pathway and steps distal to cytosolic Ca(2+) concentration elevation in glucose-induced insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211045200

Genetic modifiers of the insulin resistance phenotype in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211045200

Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M211045200

21 January 2018

Identifiers

DOI

10.1074/JBC.M211045200

1 reference

1 December 2017

1 reference